PRXL2A and hematologic disorder: In addition, genes associated with hematological disease (e.g., PDE7A, LMAN1, F13A1, OLR1) and mitochondrial biogenesis and redox (e.g., NOS3, ALDH5A1, PRXL2A, SLC25A13, CPT2) were also significantly altered in BPD patients (Table 4).